67 related articles for article (PubMed ID: 16050493)
1. [HIV reproduction inhibition by amino acid and dipeptide derivatives of fullerene C60].
Miller GG; Romanova VS; Pokidysheva LN; Titova IV; Kaliberda EN; Rumsh LD; Andreeva OI; Rybalkin NP
Antibiot Khimioter; 2004; 49(12):3-8. PubMed ID: 16050493
[TBL] [Abstract][Full Text] [Related]
2. Fullerene derivatives as dual inhibitors of HIV-1 reverse transcriptase and protease.
Yasuno T; Ohe T; Kataoka H; Hashimoto K; Ishikawa Y; Furukawa K; Tateishi Y; Kobayashi T; Takahashi K; Nakamura S; Mashino T
Bioorg Med Chem Lett; 2021 Jan; 31():127675. PubMed ID: 33161121
[TBL] [Abstract][Full Text] [Related]
3. Novel pyridinium-type fullerene derivatives as multitargeting inhibitors of HIV-1 reverse transcriptase, HIV-1 protease, and HCV NS5B polymerase.
Kobayashi T; Yasuno T; Takahashi K; Nakamura S; Mashino T; Ohe T
Bioorg Med Chem Lett; 2021 Oct; 49():128267. PubMed ID: 34271071
[TBL] [Abstract][Full Text] [Related]
4. Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Monforte AM; Logoteta P; De Luca L; Iraci N; Ferro S; Maga G; De Clercq E; Pannecouque C; Chimirri A
Bioorg Med Chem; 2010 Feb; 18(4):1702-10. PubMed ID: 20097079
[TBL] [Abstract][Full Text] [Related]
5. Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity.
Martinez ZS; Castro E; Seong CS; Cerón MR; Echegoyen L; Llano M
Antimicrob Agents Chemother; 2016 Oct; 60(10):5731-41. PubMed ID: 27431232
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of coumarin derivatives as potential dual-action HIV-1 protease and reverse transcriptase inhibitors.
Olomola TO; Klein R; Mautsa N; Sayed Y; Kaye PT
Bioorg Med Chem; 2013 Apr; 21(7):1964-71. PubMed ID: 23415084
[TBL] [Abstract][Full Text] [Related]
7. The human immunodeficiency virus-reverse transcriptase inhibition activity of novel pyridine/pyridinium-type fullerene derivatives.
Yasuno T; Ohe T; Takahashi K; Nakamura S; Mashino T
Bioorg Med Chem Lett; 2015 Aug; 25(16):3226-9. PubMed ID: 26081290
[TBL] [Abstract][Full Text] [Related]
8. Deformation density components analysis of fullerene-based anti-HIV drugs.
Fakhraee S; Souri M
J Mol Model; 2014 Nov; 20(11):2486. PubMed ID: 25388278
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.
Mashino T; Shimotohno K; Ikegami N; Nishikawa D; Okuda K; Takahashi K; Nakamura S; Mochizuki M
Bioorg Med Chem Lett; 2005 Feb; 15(4):1107-9. PubMed ID: 15686922
[TBL] [Abstract][Full Text] [Related]
10. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
[TBL] [Abstract][Full Text] [Related]
11. [In vitro antiviral activity of fullerene amino acid derivatives in cytomegalovirus infection].
Medzhidova MG; Abdullaeva MV; Fedorova NE; Romanova VS; Kushch AA
Antibiot Khimioter; 2004; 49(8-9):13-20. PubMed ID: 15727140
[TBL] [Abstract][Full Text] [Related]
12. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
[TBL] [Abstract][Full Text] [Related]
13. Molecular Dynamics Simulation Study of the HIV-1 Protease Inhibit ion Using Fullerene and New Fullerene Derivatives of Carbon Nanostructures.
Barzegar A; Naghizadeh E; Zakariazadeh M; Azamat J
Mini Rev Med Chem; 2017; 17(7):633-647. PubMed ID: 27292780
[TBL] [Abstract][Full Text] [Related]
14. Discovery of nitropyridine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors via a structure-based core refining approach.
Wang J; Zhan P; Li Z; Liu H; De Clercq E; Pannecouque C; Liu X
Eur J Med Chem; 2014 Apr; 76():531-8. PubMed ID: 24602795
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
[TBL] [Abstract][Full Text] [Related]
16. [Combination of phosphazide and crixivan inhibit replication of HIV-1 strains that are resistant to azidothymidine].
Selimova LM; Kraevskiĭ AA; Galegov GA
Dokl Akad Nauk; 1999 Dec; 369(6):847-9. PubMed ID: 10687056
[No Abstract] [Full Text] [Related]
17. Molecular modeling, synthesis and biological evaluation of N-heteroaryl compounds as reverse transcriptase inhibitors against HIV-1.
Singh A; Yadav D; Yadav M; Dhamanage A; Kulkarni S; Singh RK
Chem Biol Drug Des; 2015 Mar; 85(3):336-47. PubMed ID: 25055732
[TBL] [Abstract][Full Text] [Related]
18. New anti-HIV agents and targets.
De Clercq E
Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
[TBL] [Abstract][Full Text] [Related]
19. Rationale and experience with reverse transcriptase inhibitors and protease inhibitors.
Vella S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S58-61. PubMed ID: 8595511
[TBL] [Abstract][Full Text] [Related]
20. Analysis of amino acids in the beta7-beta8 loop of human immunodeficiency virus type 1 reverse transcriptase for their role in virus replication.
Mulky A; Vu BC; Conway JA; Hughes SH; Kappes JC
J Mol Biol; 2007 Feb; 365(5):1368-78. PubMed ID: 17141805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
